Prevalence and impact of myocardial injury among patients hospitalized with COVID-19

被引:7
|
作者
Vu, Vu Hoang [1 ,2 ]
Nguyen, Thanh Cong [2 ]
Pham, Quang Dang Duy [2 ]
Pham, Dan Ngoc [3 ]
Le, Le Bao [4 ]
Le, Khoi Minh [5 ]
机构
[1] Univ Med & Pharm, Fac Med, Ho Chi Minh City, Vietnam
[2] Univ Med Ctr Ho Chi Minh City, Intervent Cardiol Dept, Ho Chi Minh City, Vietnam
[3] Univ Med Ctr Ho Chi Minh City, Dept Cardiol, Ho Chi Minh City, Vietnam
[4] Univ Med Ctr Ho Chi Minh City, Rheumatol Dept, Ho Chi Minh City, Vietnam
[5] Univ Med Ctr Ho Chi Minh City, Cardiac Imaging Unit, Ho Chi Minh City, Vietnam
来源
关键词
COVID-19; SARS-CoV-2; myocardial injury; cardiac injury; troponin; prognosis; PNEUMONIA;
D O I
10.3389/fcvm.2023.1202332
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundMyocardial injury is a prevalent complication observed in patients hospitalized with COVID-19 and is strongly associated with severe illness and in-hospital mortality. However, the long-term consequences of myocardial injury on clinical outcomes remain poorly understood. This study aimed to assess the impact of myocardial injury on both acute-phase and long-term prognosis in COVID-19 patients.MethodsA retrospective, observational study was conducted on all patients who received treatment at the Intensive Care Center for COVID-19 patient, University Medical Center Ho Chi Minh City (UCICC), from August 3rd, 2021, to October 28th, 2021.ResultsA total of 582 patients were enrolled in the study, of which 55.3% were female. The mean age of participants was 63.3 & PLUSMN; 16.2. Out of these patients, 330 cases (56.8%) showed myocardial injury. Compared to patients without myocardial injury, those with myocardial injury were older and had a higher incidence of chronic diseases including hypertension, ischemic heart disease, atrial fibrillation, heart failure, diabetes mellitus, chronic kidney disease. They also presented with more severe respiratory failure upon admission and showed a more pronounced abnormality in inflammation and kidney function tests. Furthermore, the in-hospital mortality rate was significantly higher in the group with myocardial injury (49.7% vs 14.3%, p < 0.001). After adjusting for age, gender, comorbidities, renal function, and disease severity at admission, myocardial injury emerged as an independent risk factor for in-hospital mortality (OR = 3.758, 95% CI 1.854-7.678, p < 0.001). Among successfully discharged COVID-19 patients, the all-cause mortality rate after a median follow-up of 18.4 months was 7.9%. Patients with myocardial injury had a significantly higher long-term mortality rate compared to those without myocardial injury (14.0% vs. 3.2%, p < 0.001). However, multivariable Cox regression analysis did not find myocardial injury to be a significant predictor of long-term mortality (HR = 2.128, 95% CI 0.792-5.712, p = 0.134).ConclusionsMyocardial injury is a common and serious complication in hospitalized COVID-19 patients, associated with increased in-hospital mortality. However, it does not significantly impact long-term mortality in successfully discharged COVID-19 patients.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Acute Liver Injury in Patients Hospitalized with COVID-19
    Sobotka, Lindsay A.
    Esteban, James
    Volk, Michael L.
    Elmunzer, B. Joseph
    Rockey, Don C.
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (08) : 4204 - 4214
  • [42] IMPACT OF HISPANIC ETHNICITY ON MORTALITY AMONG HOSPITALIZED PATIENTS WITH COVID-19 DIAGNOSIS
    Adrade, Liwayway R.
    Hodgeman, Nicholas
    Mader, Michael J.
    Sanchez-Reilly, Sandra
    Restrepo, Marcos I.
    CHEST, 2022, 162 (04) : 1172A - 1172A
  • [43] Characterization of Myocardial Injury in Patients With COVID-19
    Giustino, Gennaro
    Croft, Lori B.
    Stefanini, Giulio G.
    Bragato, Renato
    Silbiger, Jeffrey J.
    Vicenzi, Marco
    Danilov, Tatyana
    Kukar, Nina
    Shaban, Nada
    Kini, Annapoorna
    Camaj, Anton
    Bienstock, Solomon W.
    Rashed, Eman R.
    Rahman, Karishma
    Oates, Connor P.
    Buckley, Samantha
    Elbaum, Lindsay S.
    Arkonac, Derya
    Fiter, Ryan
    Singh, Ranbir
    Li, Emily
    Razuk, Victor
    Robinson, Sam E.
    Miller, Michael
    Bier, Benjamin
    Donghi, Valeria
    Pisaniello, Marco
    Mantovani, Riccardo
    Pinto, Giuseppe
    Rota, Irene
    Baggio, Sara
    Chiarito, Mauro
    Fazzari, Fabio
    Cusmano, Ignazio
    Curzi, Mirko
    Ro, Richard
    Malick, Waqas
    Kamran, Mazullah
    Kohli-Seth, Roopa
    Bassily-Marcus, Adel M.
    Neibart, Eric
    MD, Gregory Serrao
    Perk, Gila
    Mancini, Donna
    Reddy, Vivek Y.
    Pinney, Sean P.
    Dangas, George
    Blasi, Francesco
    Sharma, Samin K.
    Mehran, Roxana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (18) : 2043 - 2055
  • [44] ARGs Prevalence Among Hospitalized COVID-19 Patients with Bacterial Infections and Resistome abundance
    Aly, Mahmoud
    FASEB JOURNAL, 2022, 36
  • [45] The prevalence of hyperkalemia and associated clinical characteristics and outcomes among hospitalized COVID-19 patients
    Agiro, Abiy
    Moon, Rena
    Rosenthal, Ning
    Brown, Harold
    Legg, Randall
    Amin, Alpesh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 106 - 106
  • [46] Prevalence and impact of comorbidities in hospitalized patients with COVID-19: a study from Saudi Arabia
    Alqahtani, Saad M. A.
    Al Saglan, Naif S.
    AlShehry, Ali A.
    Hawan, Ali
    Dafalla, Badraltamam A. A.
    Mohamed, Nahid A. S.
    Kadasah, Ali S.
    Qureshi, Muhammad A.
    Al-Shahrani, Nourah A.
    Alfaifi, Abdulaziz S. Y.
    Alqahtani, Mohammed A.
    Alshafa, Fawwaz A.
    Alsalem, Ali A.
    Al-Imamah, Yahya A.
    Abdullah, Alahmari
    Alzulfah, Saad A. S.
    Mahmoud, Ibrahim M. A.
    Abuelhassan, Usama E.
    EGYPTIAN JOURNAL OF BRONCHOLOGY, 2023, 17 (01)
  • [47] Prevalence of vitamin D deficiency and its prognostic impact on patients hospitalized with COVID-19
    Bianconi, Vanessa
    Mannarino, Massimo R.
    Figorilli, Filippo
    Cosentini, Elena
    Batori, Giuseppe
    Marini, Ettore
    Lombardini, Rita
    Gargaro, Marco
    Fallarino, Francesca
    Scarponi, Anna Maria
    Sahebkar, Amirhossein
    Pirro, Matteo
    NUTRITION, 2021, 91-92
  • [48] Impact of the COVID-19 Pandemic on the Prevalence of Substance Use Disorders in Medically Hospitalized Patients
    Collins, Kelsey
    Sidelnik, Simon
    Ackerman, Marra
    Chong, Celena
    Flatow, Stacey
    Siegel, Carole
    Ginsberg, David
    JOURNAL OF THE ACADEMY OF CONSULTATION-LIAISON PSYCHIATRY, 2022, 63 : S23 - S24
  • [49] Prevalence and Impact of Preexisting Comorbidities on Overall Clinical Outcomes of Hospitalized COVID-19 Patients
    Koyyada, Rajeswari
    Nagalla, Balakrishna
    Tummala, Anusha
    Singh, Anula D.
    Patnam, Sreekanth
    Barigala, Ravikiran
    Kandala, Mahati
    Krishna, Vamsi
    Manda, Sasidhar V.
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [50] Prevalence and impact of comorbidities in hospitalized patients with COVID-19: a study from Saudi Arabia
    Saad M. A. alqahtani
    Naif S. Al Saglan
    Ali A. AlShehry
    Ali Hawan
    Badraltamam A. A.Dafalla
    Nahid A. S. Mohamed
    Ali S. Kadasah
    Muhammad A.Qureshi
    Nourah A. Al-Shahrani
    Abdulaziz S. Y. Alfaifi
    Mohammed A. Alqahtani
    Fawwaz A. Alshafa
    Ali A. Alsalem
    Yahya A. Al-Imamah
    Alahmari Abdullah
    Saad A. S. Alzulfah
    Ibrahim M. A. Mahmoud
    Usama E. Abuelhassan
    The Egyptian Journal of Bronchology, 17